Form 4: Acuity Director Sachleben Receives Stock Units
Insider Transaction Report
Acuity Inc. director Mark Sachleben received 546 Deferred Restricted Stock Units as part of his annual director fees.
Summary
- Mark Sachleben, a Director of Acuity Inc. (AYI), acquired 546 Deferred Restricted Stock Units (DSUs).
- The DSUs were issued on January 21, 2026, as part of Mr. Sachleben's election to receive a portion of his annual director fees in this form.
- These DSUs will vest in full on January 21, 2027, or earlier, on the date of the next subsequent annual meeting of Acuity's stockholders following the grant date.
- Once vested, the DSUs will be payable upon Mr. Sachleben's retirement, either as a lump sum or in five annual installments.
- The number of DSUs granted was calculated based on an average share price of $320.59, derived from the high and low sales prices of Acuity's common stock over the five trading days preceding the grant date.
Sentiment
Score: 7
Explanation: The filing reports a routine compensation event for a director, which is generally viewed as neutral to slightly positive as it aligns director interests with shareholders. It does not indicate any significant operational or financial changes.
Positives
- The grant of Deferred Restricted Stock Units to a director helps align their interests with those of the shareholders, promoting long-term value creation.
- This form of compensation is a standard practice in corporate governance, indicating a structured approach to director remuneration.
Future Outlook
The Deferred Restricted Stock Units are scheduled to vest on January 21, 2027, or earlier, upon the next annual stockholders' meeting. Upon vesting, these units will be payable to Mr. Sachleben upon his retirement, either as a lump sum or in five annual installments.
Industry Context
The grant of equity-based compensation, such as Deferred Restricted Stock Units, to non-employee directors is a common practice across various industries, including the industrial technology and lighting sector where Acuity Inc. operates. This method of compensation is widely adopted to incentivize directors and align their long-term interests with those of the company's shareholders.
Comparison to Industry Standards
- Equity compensation for directors, including the use of restricted stock units or deferred stock units, is a standard practice among publicly traded companies globally.
- Many companies, including peers in the industrial and technology sectors, utilize similar long-term incentive plans to attract and retain qualified board members and align their compensation with company performance and shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | Deferred Restricted Stock Units (DSUs) were issued pursuant to the Issuer's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan, indicating ongoing use of established equity compensation frameworks. | 01/21/2026 | Reinforces the company's existing compensation structure designed to align director incentives with long-term shareholder value. |
Related Party Transactions
- The grant of Deferred Restricted Stock Units to Director Mark Sachleben constitutes a related party transaction, as it involves compensation provided to a member of the company's board of directors.
Stakeholder Impact
- Shareholders: The grant of equity to a director aligns their financial interests with those of the shareholders, potentially fostering decisions that enhance long-term shareholder value.
- Employees: No direct impact on employees is indicated by this specific director compensation filing.
Next Steps
- The Deferred Restricted Stock Units will vest on January 21, 2027, or earlier, upon the next annual meeting of stockholders.
- Payment of the vested DSUs will occur upon Mr. Sachleben's retirement, as per the terms of the compensation plan.
Key Dates
| Date | Description |
|---|---|
| 01/21/2026 | Date of grant for 546 Deferred Restricted Stock Units to Director Mark Sachleben. |
| 01/23/2026 | Date the Form 4 was signed by Chanda Kirchner, Attorney-in-Fact for Mark J. Sachleben. |
| 01/21/2027 | Scheduled vesting date for the Deferred Restricted Stock Units, or earlier, upon the next annual stockholders' meeting. |
Recommendation
holdThis Form 4 filing reports a routine grant of Deferred Restricted Stock Units to a director as part of their annual compensation. It does not provide new information that would fundamentally alter the investment thesis for Acuity Inc., thus a 'hold' recommendation remains appropriate based solely on this filing.
Keywords
Acuity Inc., AYI, Form 4, Deferred Restricted Stock Units, DSU, Director Compensation, Insider Transaction, Equity Grant, Mark Sachleben
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.